查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1862966

体外诊断包装市场：依包装类型、材料、最终用户、无菌条件、温度需求和分销管道划分－2025-2032年全球预测

In-Vitro Diagnostics Packaging Market by Packaging Format, Material, End User, Sterility, Temperature Requirement, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，体外诊断包装材料市场将成长至 132.5 亿美元，复合年增长率为 7.01%。

主要市场统计数据
基准年 2024 77亿美元
预计年份：2025年 82.4亿美元
预测年份：2032年 132.5亿美元
复合年增长率 (%) 7.01%

以完整性、可追溯性和永续性为策略导向，诊断包装正在重塑其支持临床工作流程和监管期望的方式。

体外诊断包装产业正经历一场变革，其驱动力包括加速创新、加强监管以及对供应链韧性的重视。包装不再仅仅提供容纳和保护，而是成为支撑检体生命週期内诊断准确性、生物安全性和可追溯性的基石。随着实验室、医院、照护现场机构和研究机构不断拓展检测方法，对包装解决方案的需求也迅速多元化。这种变革迫使製造商和采购团队重新思考材料选择、无菌处理以及端到端低温运输能力，以维持检体完整性并确保患者安全。

整合製造、尖端材料和数位化可追溯性的融合，正在重新定义包装在诊断准确性、物流和采购管道中的作用

产业正经历变革时期，重塑竞争格局和营运重点。无菌加工技术的进步，例如吹灌封系统和整合式盒式生产，在提高产量的同时降低了污染风险。柔性包装的创新正在优化运输重量和储存效率。这些工艺层面的创新与材料科学的突破相辅相成。特殊聚合物和配方稳定层压材料提高了阻隔性能和耐热性，从而拓展了产品在常温、冷藏和冷冻等不同温度环境下的应用范围。因此，包装正从被动的保护者转变为诊断能力和物流效率的积极推动者。

关税调整和贸易政策变化促使供应链重组和区域化生产投资，以保障诊断包装的连续性和合规性。

2025年实施的关税和贸易政策调整对原材料和成品诊断包装材料的整体进口造成了显着压力，促使生产商和采购商迅速采取战略性应对措施。关税导致的成本增加加速了对供应商所在地和合约条款的重新评估，尤其是那些来自全球供应链的组件和基材。在这种环境下，寻找替代原材料、绘製供应链图以及评估供应商风险变得更加紧迫，这些措施既要保证屏障性能和无菌性，又要确保符合监管要求。

按规格、材料、最终用户、灭菌状态、温度和分销管道进行细分，凸显了诊断包装中目标产品和市场推广的重要性。

市场区隔揭示了不同的需求模式和技术要求，从而指南产品开发和商业化策略。包装趋势倾向于吹灌封式包装（尤其是安瓿瓶、卡匣和盒式包装），因为无菌性、精确剂量和整合填充至关重要；而薄膜和复合材料、软包装袋等柔性包装则支援大容量试剂分发和轻便运输。包括微孔盘载玻片和试管管瓶的硬质包装仍然是实验室自动化和检体储存的核心，其人体工学和仪器相容性也在不断优化。

监管重点、生产能力和低温运输成熟度方面的区域差异，正在塑造诊断包装采用方面不同的策略方法。

区域趋势凸显了影响製造地、监管策略和物流投资的多元化优先事项。在美洲，对先进实验室基础设施和照护现场部署的集中需求推动了无菌、自动化相容的硬质容器的广泛应用，以及对冷藏和常温解决方案的持续需求。该地区的监管环境和采购週期正在推动对国内或邻近生产的投资，尤其是在政策变化导致进口成本上升或优先考虑供应安全的地区。

为了确保竞争优势，各公司都在加强其无菌加工能力，推动材料创新和数位化可追溯性，并扩大其服务范围和扩大本地生产。

诊断包装领域的主要企业正采取多元化的竞争策略，将技术投资与业务重组结合。许多企业正在强化其无菌加工和吹灌封 (BFS) 系统的能力，以降低污染风险并提高无菌一次性产品的生产效率。同时，材料创新专案致力于研发特殊聚合物和复合材料结构，以改善阻隔性和热稳定性，同时提高可回收性并减轻材料重量。此外，各企业也正在投资数位化工具，例如序列化、RFID 标籤和云端追溯系统，以满足客户对监管链视觉性和合规性文件的需求。

考虑整合供应链多元化、区域产能扩张和数位化可追溯性，以增强诊断包装领域的韧性、合规性和客户协作。

产业领导者可以製定重点行动计划，化挑战为优势。优先发展多元化的供应商网络，并对关键基材采取双重采购模式，以确保材料间检验的等效性，同时降低受贸易政策变化和区域生产限制的影响。增加对本地无菌填充和二次包装能力的投资，以缩短前置作业时间并降低关税风险，并将这些投资与无菌​​检验计划相结合，确保符合监管要求。将特种聚合物选项和检验的层压结构纳入产品系列，以满足常温、冷藏和冷冻应用场景下的隔热和阻隔性需求，同时推动可衡量的永续永续性目标。

本研究采用严谨的混合方法研究途径，结合相关人员访谈、技术评估和交叉检验的案例分析，旨在深入了解包装技术及其应用。

我们的调查方法结合了第一手资料和第二手资料，旨在对诊断包装行业的现状进行实证分析。第一手资料包括对来自诊断实验室、医院诊所、就地检验提供者和研究机构的包装工程师、供应链经理、法规事务专业人员和采购人员进行结构化访谈，以收集营运重点和检验方法。第二手资料包括查阅法规指南、技术标准、专利趋势、製造案例研究和科学文献，以综合分析材料在常温、冷藏和冷冻运输条件下的性能、无菌加工趋势以及低温运输要求。

对无菌处理、材料认证和数位化可追溯性的协调投资对于确保诊断的完整性和营运的韧性至关重要。

製造创新、材料科学、不断变化的法规以及贸易政策的协调一致，正在为体外诊断包装创造一种新的营运模式。包装正被视为一项策略性资产，它能够保障诊断准确性、提升供应链弹性并支持永续性。那些将无菌处理能力、特殊材料和数位化可追溯性方面的投资与区域优化製造地相结合的企业，将更有能力应对关税波动带来的影响，并满足诊断实验室、医院诊所、就地检验机构和研究机构的复杂需求。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 体外诊断包装中永续和可回收材料有助于满足监管和环境要求。
  • 将RFID和NFC等智慧包装技术整合到体外诊断试剂盒中，以增强可追溯性并提高患者安全性。
  • 开发用于照护现场体外诊断测试的密封式抛弃微流体晶片
  • 可客製化的低温运输包装解决方案，采用相变材料以在运输过程中维持生物标记的稳定性
  • 过渡到采用儿童安全防篡改包装设计，以确保符合体外诊断产品的全球安全法规。
  • 诊断设备机壳上的抗菌涂层可降低污染风险并延长保质期
  • 在体外诊断包装中引入数位和可变数据印刷技术，实现批次特异性标籤和即时品管。
  • 轻质聚合物泡壳包装：减轻包装重量，减少高频诊断测试的废弃物
  • 使用符合 ISO 13485 标准的印刷油墨和黏合剂製作体外诊断试剂容器标籤，以提高可追溯性并防止交叉污染
  • 模组化实验室晶片封装形式的成长，使得快速客製化和可扩展性成为可能，从而满足新兴感染疾病诊断的需求。

第六章美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 体外诊断包装市场：依包装形式划分

  • 吹塑-灌装-密封
    • 安瓿
    • 墨水匣和磁带
  • 软包装
    • 薄膜和层压材料
    • 小袋和包装袋
  • 硬包装
    • 微孔盘和玻片
    • 试管和管瓶

9. 体外诊断包装市场（依材料划分）

  • 玻璃
  • 塑胶
  • 特种聚合物
  • 永续材料

第十章 体外诊断包装市场（依最终用户划分）

  • 诊断实验室
  • 医院诊所
  • 就地检验
  • 研究所

第十一章 以灭菌状态分類的体外诊断包装市场

  • 非无菌
  • 无菌

12. 体外诊断包装市场依温度要求划分

  • 常温
  • 冷冻
  • 冷藏

第十三章 体外诊断包装市场（依通路划分）

  • 直销
  • 批发商
  • 在线的

第十四章 体外诊断包装市场（依地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 体外诊断包装市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 各国体外诊断包装市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Amcor plc
    • Berry Global Group, Inc.
    • Gerresheimer AG
    • Stevanato Group SpA
    • West Pharmaceutical Services, Inc.
    • AptarGroup, Inc.
    • SCHOTT AG
    • Constantia Flexibles Group GmbH
    • Nelipak Corporation
    • Lohmann GmbH & Co. KG
Product Code: MRR-F6513A06BD97

The In-Vitro Diagnostics Packaging Market is projected to grow by USD 13.25 billion at a CAGR of 7.01% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 7.70 billion
Estimated Year [2025] USD 8.24 billion
Forecast Year [2032] USD 13.25 billion
CAGR (%) 7.01%

A strategic orientation toward integrity, traceability, and sustainability is reshaping how diagnostic packaging supports clinical workflows and regulatory expectations

The in-vitro diagnostics packaging landscape stands at a pivotal juncture driven by accelerating innovation, heightened regulatory scrutiny, and an intensified emphasis on supply chain resilience. Packaging functions no longer serve solely as containment and protection; they underpin diagnostic accuracy, biosafety, and traceability across the specimen lifecycle. As laboratories, hospitals, point-of-care providers, and research institutions expand testing modalities, the demand profile for packaging solutions has diversified rapidly. This transformation compels manufacturers and procurement teams to rethink material choices, aseptic processing, and end-to-end cold chain capabilities to maintain sample integrity and ensure patient safety.

Concurrently, sustainability ambitions and circular-economy objectives are influencing material selection and end-of-life considerations. Advances in specialty polymers and recyclable substrates are converging with legacy materials like glass and traditional plastics, prompting stakeholders to weigh performance against environmental impact. Regulatory authorities are also refining expectations for sterility validation and labeling, which further elevates the role of packaging as a compliance instrument. The combined effect of these forces requires cross-functional collaboration between packaging engineers, quality and regulatory teams, and commercial stakeholders to create robust, scalable solutions that meet clinical and operational realities.

Integrated manufacturing, advanced materials, and digital traceability are converging to redefine packaging's role in diagnostic accuracy, logistics, and procurement channels

The sector is experiencing transformative shifts that reconfigure competitive dynamics and operational priorities. Advances in aseptic processing technologies such as blow-fill-seal systems and integrated cartridge production are enabling higher throughput with reduced contamination risk, while flexible packaging innovations are optimizing transport weight and storage efficiency. These process-level innovations are complemented by materials science breakthroughs: specialty polymers and formulation-stable laminates are improving barrier properties and thermal tolerance, enabling expanded use cases across ambient, refrigerated, and frozen temperature requirements. As a result, packaging is evolving from passive protection to an active enabler of diagnostic performance and logistics efficiency.

Market participants are also adapting to an omnichannel procurement environment. Direct sales relationships coexist with distributor networks and online platforms, reshaping go-to-market strategies and customer engagement models. This shift drives demand for standardized technical dossiers and digital assets that support remote evaluation and qualification. Additionally, digital traceability systems and serialization are becoming expected features for high-value or regulated diagnostic shipments, creating new interoperability challenges and data governance obligations. Together, these shifts demand integrated roadmaps that align manufacturing capability, materials sourcing, and digital infrastructure to preserve product quality while improving cost and time efficiencies.

Tariff adjustments and trade policy changes have catalyzed supply chain realignment and regional production investments to protect diagnostic packaging continuity and compliance

The imposition of tariffs and trade policy adjustments in the United States during 2025 has exerted measurable pressure across inbound raw materials and finished diagnostic packaging imports, prompting rapid strategic responses from manufacturers and buyers alike. Tariff-driven cost escalation accelerated the reassessment of supplier footprints and contractual terms, particularly for components and substrates sourced from global supply nodes. This environment has increased the urgency for supply chain mapping, supplier risk assessments, and the identification of alternative raw material options that maintain barrier performance and sterility assurance without compromising regulatory compliance.

In response, many organizations have pursued nearshoring or dual-sourcing strategies to mitigate exposure to tariff volatility and cross-border customs delays. These moves often entail capital investment in regional aseptic filling and packaging capabilities, as well as renegotiation of logistics arrangements to preserve cold-chain integrity for refrigerated and frozen shipments. Price pressures have driven tighter inventory management, a shift toward longer-term supplier agreements with tariff pass-through clauses, and the acceleration of supplier qualification processes to shorten lead times. Policymakers' actions also incentivized collaboration between industry and regulators to clarify classification, harmonize certification requirements, and expedite customs processes for critical diagnostic supplies, which has reduced clearance uncertainty even as duty costs remain a factor in procurement decisions.

Granular segmentation across format, material, end-user, sterility, temperature, and distribution reveals targeted product and go-to-market imperatives for diagnostic packaging

Segmentation reveals differentiated demand patterns and technical requirements that inform product development and commercialization strategies. Packaging format dynamics show that blow-fill-seal solutions, particularly ampoules and cartridges & cassettes, are favored where sterility, precision dosing, and integrated filling are critical, while flexible packaging such as film & laminates and pouches & bags supports high-volume reagent distribution and lightweight transport. Rigid packaging categories, encompassing microplates & slides and tubes & vials, remain central to laboratory automation and sample storage, with ongoing optimization for ergonomic handling and instrument compatibility.

Material selection strongly shapes performance and environmental outcomes, with traditional glass persisting in high-purity applications while plastics deliver impact resistance and design flexibility. Specialty polymers have emerged to fulfill demanding barrier and thermal profiles, and sustainable materials are increasingly incorporated to address end-of-life and procurement sustainability mandates. End users drive divergent packaging requirements: diagnostic laboratories prioritize automation compatibility and throughput; hospitals and clinics value sterility, clinician usability, and storage efficiency; point-of-care testing demands compact, robust, and easy-to-use formats; research institutes seek customizable formats for experimental workflows. Sterility requirements bifurcate solutions between sterile and non-sterile applications, each with distinct validation and handling workflows. Temperature requirements create separate value chains for ambient, frozen, and refrigerated shipments, influencing material choices and secondary packaging. Finally, distribution channels-direct sales, distributors, and online-shape customer experience, qualification timelines, and aftermarket support, necessitating tailored service and technical documentation for each route to market.

Regional differences in regulatory priorities, manufacturing capacity, and cold chain maturity are shaping divergent strategic approaches to diagnostic packaging deployment

Regional dynamics underscore heterogeneous priorities that influence manufacturing footprint, regulatory strategies, and logistics investment. In the Americas, demand concentrates on advanced laboratory infrastructure and point-of-care rollout, creating robust uptake for sterile, automation-ready rigid formats and a sustained need for refrigerated and ambient solutions. The region's regulatory landscape and procurement cycles encourage investments in domestic or nearshore production, particularly where policy shifts increase the cost of imports or prioritize supply security.

Europe, the Middle East and Africa present a mosaic of regulatory stringency and sustainability focus. Western European markets emphasize material recyclability, extended producer responsibility, and tight sterility controls, which in turn accelerate adoption of specialty polymers and validated sterilization pathways. In EMEA markets where centralized lab networks coexist with decentralized testing, packaging solutions must balance cost-efficiency with traceability and compatibility across diverse cold chain infrastructures. The Asia-Pacific region combines large-scale manufacturing capacity, rapidly expanding diagnostic access, and divergent logistics maturity. Strong production clusters in the region enable competitive sourcing of both glass and polymer formats, but heterogeneity in cold chain and regulatory harmonization requires localized validation strategies and adaptable packaging designs to meet varied end-user needs.

Companies are reinforcing aseptic capability, materials innovation, and digital traceability while expanding service bundles and regional production to secure competitive advantage

Leading companies in the diagnostic packaging space are pursuing an array of competitive strategies that combine technological investment with commercial realignment. Many are deepening capabilities in aseptic processing and blow-fill-seal systems to reduce contamination risk and accelerate throughput for sterile single-use products. Simultaneously, materials innovation programs target specialty polymers and laminate constructions that improve barrier and thermal stability while enabling recyclability or reduced material mass. Firms are also investing in digital tools such as serialization, RFID tagging, and cloud-enabled traceability to meet customer demands for chain-of-custody visibility and compliance documentation.

Commercially, players are expanding service offerings that pair packaging with analytical support, qualification packs, and regulatory dossiers to simplify customer adoption and shorten qualification cycles. Strategic partnerships and targeted acquisitions have become common to access niche capabilities, scale manufacturing, and extend distribution networks. In parallel, quality and regulatory teams within these companies are enhancing sterility validation protocols and cold chain qualification to support refrigerated and frozen shipments, reflecting the broader market emphasis on preserving sample integrity across diverse temperature requirements. Together, these initiatives signal a surge in vertically integrated approaches that combine materials expertise, aseptic manufacturing, and aftermarket services to reinforce competitive differentiation.

Adopt integrated supply diversification, regional capacity buildouts, and digital traceability to strengthen resilience, compliance, and customer alignment in diagnostic packaging

Industry leaders can adopt a focused set of actions to convert disruption into advantage. Prioritize diversified supplier networks and dual-source critical substrates to mitigate exposure to trade policy shifts and regional production constraints while maintaining validated equivalency across materials. Invest in regional aseptic filling and secondary packaging capacity to reduce lead times and tariff exposure, and align those investments with sterility validation programs to ensure regulatory readiness. Incorporate specialty polymer options and validated laminate constructions into product portfolios to address thermal and barrier needs across ambient, refrigerated, and frozen use cases while also advancing measurable sustainability goals.

Enhance digital capabilities by deploying serialization and real-time traceability systems that integrate with customer laboratory information management systems and distribution partners. Tailor go-to-market models for different channels: strengthen direct sales engagement for strategic accounts, streamline qualification kits and technical documentation for distributors, and optimize digital assets and e-commerce capabilities for online procurement. Pair technology investments with commercial incentives such as flexible contract terms and inventory consignment models to stabilize supply for key end users like diagnostic laboratories, hospitals and clinics, point-of-care providers, and research institutes. Finally, institutionalize cross-functional decision-making processes that bring procurement, quality, regulatory, and operations together to accelerate supplier qualification, change control, and new product introductions.

A rigorous mixed-methods research approach blended stakeholder interviews, technical reviews, and cross-validated case analyses to produce actionable insights into packaging technologies and adoption

The research methodology combined primary and secondary investigative approaches to produce an evidence-based view of the diagnostic packaging landscape. Primary research incorporated structured interviews with packaging engineers, supply chain leaders, regulatory affairs specialists, and procurement heads across diagnostic laboratories, hospitals and clinics, point-of-care testing providers, and research institutes to capture operational priorities and validation practices. Secondary investigation reviewed regulatory guidances, technical standards, patent activity, manufacturing case studies, and scientific literature to triangulate material performance, aseptic processing trends, and cold chain requirements for ambient, refrigerated, and frozen shipments.

Data validation and synthesis involved cross-referencing interview insights with manufacturing and logistics case examples, ensuring that material choices and format preferences reflect real-world adoption patterns. Segment-level analysis was informed by format-specific technical comparisons-examining blow-fill-seal ampoules and cartridges & cassettes, flexible film & laminate constructions and pouches & bags, as well as rigid microplates & slides alongside tubes & vials-while mapping material properties across glass, plastic, specialty polymers, and sustainable materials. The methodology also evaluated distribution channel behaviors across direct sales, distributors, and online platforms to reflect procurement realities. Limitations include variations in regional regulations and the pace of technology adoption, which were mitigated by validating findings with multiple stakeholders and prioritizing conservative interpretation where practices diverged significantly.

Coordinated investments in aseptic processing, materials qualification, and digital traceability are critical to secure diagnostic integrity and operational resilience

The convergence of manufacturing innovation, materials science, regulatory evolution, and trade policy adjustments is setting a new operating paradigm for in-vitro diagnostics packaging. Packaging is increasingly recognized as a strategic asset that safeguards diagnostic fidelity, enables supply chain agility, and supports sustainability commitments. Organizations that align investments in aseptic capabilities, specialty materials, and digital traceability with regionally optimized manufacturing footprints will be best positioned to manage tariff-driven volatility and fulfill the nuanced needs of diagnostic laboratories, hospitals and clinics, point-of-care testers, and research institutes.

Moving forward, success will depend on the ability to execute coordinated strategies that integrate product development, regulatory planning, and commercial deployment. Stakeholders that institutionalize supplier diversification, accelerate material qualification protocols, and deploy traceability systems will reduce operational risk while improving time-to-market. In short, proactive alignment of technical capability and commercial strategy is the most reliable path to preserving sample integrity, meeting evolving regulatory demands, and capturing the strategic benefits that flow from a resilient, future-ready packaging ecosystem.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of sustainable and recyclable materials in in-vitro diagnostics packaging to meet regulatory and environmental demands
  • 5.2. Integration of smart packaging technologies like RFID and NFC for enhanced traceability and patient safety in IVD kits
  • 5.3. Development of single-use microfluidic cartridges with hermetic sealing for point-of-care in-vitro diagnostic tests
  • 5.4. Customizable cold chain packaging solutions incorporating phase change materials to preserve biomarker stability during transportation
  • 5.5. Shift towards child-resistant and tamper-evident packaging designs to ensure compliance with global safety regulations for IVD products
  • 5.6. Use of antimicrobial coatings on diagnostic device casings to reduce contamination risks and extend shelf life
  • 5.7. Implementation of digital printing and variable data printing for batch-specific labeling and real-time quality control in IVD packaging
  • 5.8. Examination of lightweight polymeric blister packs to reduce packaging weight and minimize waste in high-volume diagnostic assays
  • 5.9. Adoption of ISO 13485 compliant printing inks and adhesives to improve traceability and prevent cross contamination in IVD container labels
  • 5.10. Growth of modular lab-on-chip packaging formats enabling rapid customization and scalability for emerging infectious disease diagnostics

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. In-Vitro Diagnostics Packaging Market, by Packaging Format

  • 8.1. Blow-Fill-Seal
    • 8.1.1. Ampoules
    • 8.1.2. Cartridges & Cassettes
  • 8.2. Flexible Packaging
    • 8.2.1. Film & Laminates
    • 8.2.2. Pouches & Bags
  • 8.3. Rigid Packaging
    • 8.3.1. Microplates & Slides
    • 8.3.2. Tubes & Vials

9. In-Vitro Diagnostics Packaging Market, by Material

  • 9.1. Glass
  • 9.2. Plastic
  • 9.3. Specialty Polymers
  • 9.4. Sustainable Materials

10. In-Vitro Diagnostics Packaging Market, by End User

  • 10.1. Diagnostic Laboratories
  • 10.2. Hospitals & Clinics
  • 10.3. Point-Of-Care Testing
  • 10.4. Research Institutes

11. In-Vitro Diagnostics Packaging Market, by Sterility

  • 11.1. Non-Sterile
  • 11.2. Sterile

12. In-Vitro Diagnostics Packaging Market, by Temperature Requirement

  • 12.1. Ambient
  • 12.2. Frozen
  • 12.3. Refrigerated

13. In-Vitro Diagnostics Packaging Market, by Distribution Channel

  • 13.1. Direct Sales
  • 13.2. Distributors
  • 13.3. Online

14. In-Vitro Diagnostics Packaging Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. In-Vitro Diagnostics Packaging Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. In-Vitro Diagnostics Packaging Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Amcor plc
    • 17.3.2. Berry Global Group, Inc.
    • 17.3.3. Gerresheimer AG
    • 17.3.4. Stevanato Group S.p.A.
    • 17.3.5. West Pharmaceutical Services, Inc.
    • 17.3.6. AptarGroup, Inc.
    • 17.3.7. SCHOTT AG
    • 17.3.8. Constantia Flexibles Group GmbH
    • 17.3.9. Nelipak Corporation
    • 17.3.10. Lohmann GmbH & Co. KG

LIST OF FIGURES

  • FIGURE 1. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PACKAGING FORMAT, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PACKAGING FORMAT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MATERIAL, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILITY, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILITY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. IN-VITRO DIAGNOSTICS PACKAGING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. IN-VITRO DIAGNOSTICS PACKAGING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. IN-VITRO DIAGNOSTICS PACKAGING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PACKAGING FORMAT, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PACKAGING FORMAT, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BLOW-FILL-SEAL, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BLOW-FILL-SEAL, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BLOW-FILL-SEAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BLOW-FILL-SEAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BLOW-FILL-SEAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BLOW-FILL-SEAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BLOW-FILL-SEAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BLOW-FILL-SEAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY AMPOULES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY AMPOULES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY AMPOULES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY AMPOULES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY AMPOULES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY AMPOULES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY CARTRIDGES & CASSETTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY CARTRIDGES & CASSETTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY CARTRIDGES & CASSETTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY CARTRIDGES & CASSETTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY CARTRIDGES & CASSETTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY CARTRIDGES & CASSETTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FLEXIBLE PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FLEXIBLE PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FLEXIBLE PACKAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FLEXIBLE PACKAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FLEXIBLE PACKAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FLEXIBLE PACKAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FLEXIBLE PACKAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FLEXIBLE PACKAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FILM & LAMINATES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FILM & LAMINATES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FILM & LAMINATES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FILM & LAMINATES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FILM & LAMINATES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FILM & LAMINATES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY POUCHES & BAGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY POUCHES & BAGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY POUCHES & BAGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY POUCHES & BAGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY POUCHES & BAGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY POUCHES & BAGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RIGID PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RIGID PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RIGID PACKAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RIGID PACKAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RIGID PACKAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RIGID PACKAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RIGID PACKAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RIGID PACKAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MICROPLATES & SLIDES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MICROPLATES & SLIDES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MICROPLATES & SLIDES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MICROPLATES & SLIDES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MICROPLATES & SLIDES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MICROPLATES & SLIDES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TUBES & VIALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TUBES & VIALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TUBES & VIALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TUBES & VIALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TUBES & VIALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TUBES & VIALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY GLASS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY GLASS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY GLASS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY GLASS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY GLASS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY GLASS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PLASTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PLASTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PLASTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PLASTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PLASTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PLASTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY SPECIALTY POLYMERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY SPECIALTY POLYMERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY SPECIALTY POLYMERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY SPECIALTY POLYMERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY SPECIALTY POLYMERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY SPECIALTY POLYMERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY SUSTAINABLE MATERIALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY SUSTAINABLE MATERIALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY SUSTAINABLE MATERIALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY SUSTAINABLE MATERIALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY SUSTAINABLE MATERIALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY SUSTAINABLE MATERIALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY POINT-OF-CARE TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY POINT-OF-CARE TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY POINT-OF-CARE TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY POINT-OF-CARE TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY POINT-OF-CARE TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY POINT-OF-CARE TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILITY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILITY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY NON-STERILE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY NON-STERILE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY NON-STERILE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY NON-STERILE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY NON-STERILE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY NON-STERILE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY AMBIENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY AMBIENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY AMBIENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY AMBIENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY AMBIENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY AMBIENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FROZEN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FROZEN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FROZEN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FROZEN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FROZEN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FROZEN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY REFRIGERATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY REFRIGERATED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY REFRIGERATED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY REFRIGERATED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY REFRIGERATED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY REFRIGERATED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY ONLINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY ONLINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY ONLINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY ONLINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 176. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 177. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PACKAGING FORMAT, 2018-2024 (USD MILLION)
  • TABLE 178. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PACKAGING FORMAT, 2025-2032 (USD MILLION)
  • TABLE 179. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BLOW-FILL-SEAL, 2018-2024 (USD MILLION)
  • TABLE 180. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BLOW-FILL-SEAL, 2025-2032 (USD MILLION)
  • TABLE 181. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FLEXIBLE PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 182. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FLEXIBLE PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 183. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RIGID PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 184. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RIGID PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 185. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 186. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 187. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 188. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 189. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILITY, 2018-2024 (USD MILLION)
  • TABLE 190. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILITY, 2025-2032 (USD MILLION)
  • TABLE 191. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2024 (USD MILLION)
  • TABLE 192. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2025-2032 (USD MILLION)
  • TABLE 193. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 194. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. NORTH AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. NORTH AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PACKAGING FORMAT, 2018-2024 (USD MILLION)
  • TABLE 198. NORTH AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PACKAGING FORMAT, 2025-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BLOW-FILL-SEAL, 2018-2024 (USD MILLION)
  • TABLE 200. NORTH AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BLOW-FILL-SEAL, 2025-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FLEXIBLE PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 202. NORTH AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FLEXIBLE PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 203. NORTH AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RIGID PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 204. NORTH AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RIGID PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 206. NORTH AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 208. NORTH AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 209. NORTH AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILITY, 2018-2024 (USD MILLION)
  • TABLE 210. NORTH AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILITY, 2025-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2024 (USD MILLION)
  • TABLE 212. NORTH AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2025-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 214. NORTH AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. LATIN AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PACKAGING FORMAT, 2018-2024 (USD MILLION)
  • TABLE 218. LATIN AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PACKAGING FORMAT, 2025-2032 (USD MILLION)
  • TABLE 219. LATIN AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BLOW-FILL-SEAL, 2018-2024 (USD MILLION)
  • TABLE 220. LATIN AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BLOW-FILL-SEAL, 2025-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FLEXIBLE PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 222. LATIN AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FLEXIBLE PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 223. LATIN AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RIGID PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 224. LATIN AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RIGID PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 225. LATIN AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 226. LATIN AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 227. LATIN AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 228. LATIN AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 229. LATIN AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILITY, 2018-2024 (USD MILLION)
  • TABLE 230. LATIN AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILITY, 2025-2032 (USD MILLION)
  • TABLE 231. LATIN AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2024 (USD MILLION)
  • TABLE 232. LATIN AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2025-2032 (USD MILLION)
  • TABLE 233. LATIN AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 234. LATIN AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PACKAGING FORMAT, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PACKAGING FORMAT, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BLOW-FILL-SEAL, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BLOW-FILL-SEAL, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FLEXIBLE PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FLEXIBLE PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RIGID PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RIGID PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILITY, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILITY, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PACKAGING FORMAT, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PACKAGING FORMAT, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BLOW-FILL-SEAL, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BLOW-FILL-SEAL, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FLEXIBLE PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FLEXIBLE PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RIGID PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RIGID PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILITY, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILITY, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 275. MIDDLE EAST IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 276. MIDDLE EAST IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 277. MIDDLE EAST IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PACKAGING FORMAT, 2018-2024 (USD MILLION)
  • TABLE 278. MIDDLE EAST IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PACKAGING FORMAT, 2025-2032 (USD MILLION)
  • TABLE 279. MIDDLE EAST IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BLOW-FILL-SEAL, 2018-2024 (USD MILLION)
  • TABLE 280. MIDDLE EAST IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BLOW-FILL-SEAL, 2025-2032 (USD MILLION)
  • TABLE 281. MIDDLE EAST IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FLEXIBLE PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 282. MIDDLE EAST IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FLEXIBLE PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 283. MIDDLE EAST IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RIGID PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 284. MIDDLE EAST IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RIGID PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 285. MIDDLE EAST IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 286. MIDDLE EAST IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 287. MIDDLE EAST IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 288. MIDDLE EAST IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 289. MIDDLE EAST IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILITY, 2018-2024 (USD MILLION)
  • TABLE 290. MIDDLE EAST IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILITY, 2025-2032 (USD MILLION)
  • TABLE 291. MIDDLE EAST IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2024 (USD MILLION)

TABLE 29